CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 56 filers reported holding CARDIFF ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 18.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,700,656 | -5.4% | 1,942,918 | 0.0% | 0.00% | – |
| Q2 2023 | $2,856,089 | -10.9% | 1,942,918 | 0.0% | 0.00% | – |
| Q1 2023 | $3,205,815 | +17.9% | 1,942,918 | 0.0% | 0.00% | – |
| Q4 2022 | $2,720,085 | -9.0% | 1,942,918 | +0.0% | 0.00% | – |
| Q3 2022 | $2,990,000 | -22.6% | 1,942,048 | +10.6% | 0.00% | – |
| Q2 2022 | $3,862,000 | -18.6% | 1,755,656 | -8.2% | 0.00% | – |
| Q1 2022 | $4,745,000 | -59.7% | 1,913,413 | -2.3% | 0.00% | – |
| Q4 2021 | $11,773,000 | -2.5% | 1,958,935 | +8.1% | 0.00% | – |
| Q3 2021 | $12,074,000 | +10.3% | 1,812,948 | +10.1% | 0.00% | – |
| Q2 2021 | $10,946,000 | -24.9% | 1,646,044 | +4.6% | 0.00% | – |
| Q1 2021 | $14,575,000 | -47.6% | 1,573,910 | +1.8% | 0.00% | -100.0% |
| Q4 2020 | $27,819,000 | +90.1% | 1,546,377 | +49.9% | 0.00% | – |
| Q3 2020 | $14,635,000 | +892.2% | 1,031,402 | +250.4% | 0.00% | – |
| Q2 2020 | $1,475,000 | – | 294,376 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $15,158,000 | 12.39% |
| Octagon Capital Advisors LP | 982,753 | $5,906,000 | 1.15% |
| Altium Capital Management LP | 337,000 | $2,025,000 | 0.56% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $616,000 | 0.44% |
| Eventide Asset Management | 1,670,399 | $10,039,000 | 0.13% |
| Artal Group S.A. | 750,000 | $4,508,000 | 0.12% |
| Aquatic Capital Management LLC | 8,000 | $48,000 | 0.09% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 17,300 | $104,000 | 0.06% |
| Anson Funds Management LP | 69,381 | $417,000 | 0.04% |
| KENNEDY CAPITAL MANAGEMENT LLC | 170,447 | $1,024,000 | 0.02% |